Elevation of heme oxygenase-1 by proteasome inhibition affords dopaminergic neuroprotection

Journal of Neuroscience Research

Volumn 88, Issue 9, 2010, Pages 1934-1942

  Yamamoto, Noriyuki ^a   Izumi, Yasuhiko ^a   Matsuo, Takaaki ^a   Wakita, Seiko ^a   Kume, Toshiaki ^a   Takada Takatori, Yuki ^b   Sawada, Hideyuki ^c   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^c UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Heme oxygenase 1; Neuroprotection; Parkinson disease; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BILIRUBIN; CARBON MONOXIDE; CYCLOHEXIMIDE; HEME OXYGENASE 1; LACTACYSTIN; MESSENGER RNA; OXIDOPAMINE; PROTEASOME; PROTOPORPHYRIN ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CATALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO; GENE OVEREXPRESSION; INHIBITION KINETICS; MESENCEPHALON; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; ENZYME STABILITY; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MESENCEPHALON; NEURONS; PC12 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RNA, MESSENGER; UBIQUITINATION;

EID: 77953483653     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22363     Document Type: Article

References (43)

1. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. 1999. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274:26071-26078. (Pubitemid 129520030)
2. Brouard S, Otterbein LE, Anrather J. 2000. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1026.
3. Brüne B, Ullrich V. 1987. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32:497-504.
4. Bush KT, Goldberg AL, Nigam SK. 1997. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 272:9086-9092.
5. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. 2009. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci U S A 106:2933-2938.
6. De Domenico I, Vaughn MB, Li L, Bagley D, Musci G, Ward DM, Kaplan J. 2006. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J 25:5396-5404.
7. Ewing JF, Maines MD. 1995. Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript. Brain Res 672:29-41.
8. Inden M, Kondo J, Kitamura Y, Takata K, Nishimura K, Taniguchi T, Sawada H, Shimohama S. 2005. Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. J Pharmacol Sci 97:203-211.
9. Izumi Y, Yamamoto N, Matsuo T, Wakita S, Takeuchi H, Kume T, Katsuki H, Sawada H, Akaike A. 2009. Vulnerability to glutamate toxicity of dopaminergic neurons is dependent on endogenous dopamine and MAPK activation. J Neurochem 110:745-755.
10. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608. (Pubitemid 28207717)
11. Kraft AD, Johnson DA, Johnson JA. 2004. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24:1101-1112.
12. Liang Q, Liou AK, Ding Y, Cao G, Xiao X, Perez RG, Chen J. 2004. 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. J Neurosci Res 77:747-761.
13. Lin PH, Chiang MT, Chau LY. 2008. Ubiquitin-proteasome system mediates heme oxygenase-1 degradation through endoplasmic reticulum-associated degradation pathway. Biochim Biophys Acta 1783: 1826-1834.
14. Lundgren J, Masson P, Mirzaei Z, Young P. 2005. Identification and characterization of a Drosophila proteasome regulatory network. Mol Cell Biol 25:4662-4675.
15. Mancuso C, Pani G, Calabrese V. 2006. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep 11: 207-213.
16. McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW. 2003. Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179:38-46.
17. Neuzil J, Stocker R. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 269:16712-16719. (Pubitemid 24200431)
18. Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278:4536-4541.
19. Nittis T, Gitlin JD. 2004. Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J Biol Chem 279: 25696-25702.
20. Otterbein LE, Bach FH, Alam J. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428.
21. Phillips JB, Williams AJ, Adams J, Elliott PJ, Tortella FC. 2000. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 31:1686-1693. (Pubitemid 30437524)
22. Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, Choi AM. 1995. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1:827-837. (Pubitemid 3013090)
23. Rebouche CJ, Wilcox CL, Widness JA. 2004. Microanalysis of nonheme iron in animal tissues. J Biochem Biophys Methods 58:239-251.
24. Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Yamamoto N, Akaike A, Inden M, Kitamura Y, Taniguchi T, Shimohama S. 2004. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J Biol Chem. 279:10710-10719.
25. Scapagnini G, D'Agata V, Calabrese V, Pascale A, Colombrita C, Alkon D, Cavallaro S. 2002. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954:51-59.
26. Schipper HM, Liberman A, Stopa EG. 1998. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150:60-68.
27. Sekhar KR, Yan XX, Freeman ML. 2002. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 21:6829-6834.
28. Siebert A, Desai V, Chandrasekaran K, Fiskum G, Jafri MS. 2009. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res 87:1659-1669.
29. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB. 1991. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978-982. (Pubitemid 21922711)
30. Song L, Song W, Schipper HM. 2007. Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. J Neurosci Res 85:2186-2195.
31. Suttner DM, Dennery PA. 1999. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 13: 1800-1809.
32. Takeda A, Onodera H, Sugimoto A, Itoyama Y, Kogure K, Shibahara S. 1994. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 666:120-124.
33. Takeda A, Kimpara T, Onodera H, Itoyama Y, Shibahara S, Kogure K. 1996. Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci Lett 205:169-172.
34. van Leyen K, Siddiq A, Ratan RR, Lo EH. 2005. Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem 92:824-830.
35. Ventii KH, Wilkinson KD. 2008. Protein partners of deubiquitinating enzymes. Biochem J 414:161-175.
36. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. 1993. Carbon monoxide: a putative neural messenger. Science 259:381-384. (Pubitemid 23055683)
37. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. 2003. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629-652. (Pubitemid 36713668)
38. Wojcik C, Di Napoli M. 2004. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke 35:1506-1518.
39. Wu WK, Volta V, Cho CH, Wu YC, Li HT, Yu L, Li ZJ, Sung JJ. 2009. Repression of protein translation and mTOR signaling by proteasome inhibitor in colon cancer cells. Biochem Biophys Res Commun 386:598-601.
40. Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW. 2004. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem J 379:587-593.
41. Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S, Akaike A. 2007. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J Biol Chem 282:4364-4372.
42. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, Lee PJ. 2003. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 278:22061-22070.
43. Zucker SD, Goessling W, Hoppin AG. 1999. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 274:10852-10862.